Tianjin Pharmaceutical Da Ren Tang Group Balance Sheet Health
Financial Health criteria checks 5/6
Tianjin Pharmaceutical Da Ren Tang Group has a total shareholder equity of CN¥6.5B and total debt of CN¥1.3B, which brings its debt-to-equity ratio to 19.8%. Its total assets and total liabilities are CN¥11.0B and CN¥4.5B respectively. Tianjin Pharmaceutical Da Ren Tang Group's EBIT is CN¥796.8M making its interest coverage ratio -3. It has cash and short-term investments of CN¥1.5B.
Key information
19.8%
Debt to equity ratio
CN¥1.28b
Debt
| Interest coverage ratio | -3x |
| Cash | CN¥1.50b |
| Equity | CN¥6.45b |
| Total liabilities | CN¥4.52b |
| Total assets | CN¥10.97b |
Recent financial health updates
Is Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) A Risky Investment?
Nov 03
We Think Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Can Manage Its Debt With Ease
Jun 20Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Has A Pretty Healthy Balance Sheet
Feb 03Recent updates
Is Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) A Risky Investment?
Nov 03Is Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14) Expensive For A Reason? A Look At Its Intrinsic Value
Aug 08Should You Be Adding Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) To Your Watchlist Today?
Jul 21We Think Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Can Manage Its Debt With Ease
Jun 20If EPS Growth Is Important To You, Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Presents An Opportunity
Apr 17Calculating The Intrinsic Value Of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)
Mar 01Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Has A Pretty Healthy Balance Sheet
Feb 03Financial Position Analysis
Short Term Liabilities: T14's short term assets (CN¥7.1B) exceed its short term liabilities (CN¥4.2B).
Long Term Liabilities: T14's short term assets (CN¥7.1B) exceed its long term liabilities (CN¥323.7M).
Debt to Equity History and Analysis
Debt Level: T14 has more cash than its total debt.
Reducing Debt: T14's debt to equity ratio has increased from 1.5% to 19.8% over the past 5 years.
Debt Coverage: T14's debt is well covered by operating cash flow (91.8%).
Interest Coverage: T14 earns more interest than it pays, so coverage of interest payments is not a concern.